New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

# “While aspirin has been studied for colorectal cancer prevention, its modest benefit and bleeding risks limit its use.

Opportunities in the colorectal cancer drugs market include growth in targeted therapy and immunotherapy, advancements in ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Diabetes is an ongoing medical condition that affects millions of people across the globe. Blood sugar needs to be controlled ...

Low dose of a hot flush medication (megestrol acetate) halts breast cancer growth, providing an economical way to improve ...

Innovent Biologics has received China’s NMPA approval for the NDA for Tabosun, a CTLA-4 monoclonal antibody for colon cancer.

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...